BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
PRAX
Price
$178.15
Change
-$5.46 (-2.97%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
4.59B
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs PRAX

Header iconBEAM vs PRAX Comparison
Open Charts BEAM vs PRAXBanner chart's image
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$108.35K
Capitalization2.2B
Praxis Precision Medicines
Price$178.15
Change-$5.46 (-2.97%)
Volume$15.72K
Capitalization4.59B
BEAM vs PRAX Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. PRAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BEAM: $21.87 vs. PRAX: $183.61)
Brand notoriety: BEAM and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. PRAX: 46%
Market capitalization -- BEAM: $2.2B vs. PRAX: $4.45B
BEAM [@Biotechnology] is valued at $2.2B. PRAX’s [@Biotechnology] market capitalization is $4.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • PRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -5.20% price change this week, while PRAX (@Biotechnology) price change was +11.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

PRAX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($4.59B) has a higher market cap than BEAM($2.2B). PRAX YTD gains are higher at: 138.578 vs. BEAM (-11.815). PRAX has higher annual earnings (EBITDA): -271.35M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. PRAX (301M). PRAX has less debt than BEAM: PRAX (755K) vs BEAM (155M). BEAM has higher revenues than PRAX: BEAM (60.3M) vs PRAX (7.77M).
BEAMPRAXBEAM / PRAX
Capitalization2.2B4.59B48%
EBITDA-414.33M-271.35M153%
Gain YTD-11.815138.578-9%
P/E RatioN/AN/A-
Revenue60.3M7.77M777%
Total Cash1.15B301M382%
Total Debt155M755K20,530%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPRAX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
PRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVIX11.330.06
+0.53%
American Century Focused Lg Cap Val Inv
MCBVX29.940.10
+0.34%
MFS Mid Cap Value B
PECAX15.710.02
+0.13%
JPMorgan SMID Cap Equity A
JOMMX16.03-0.01
-0.06%
JOHCM Emerging Mkts Discovery Instl
WBVRX29.54-0.02
-0.07%
William Blair Small Cap Value R6

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+0.03%
BEAM - PRAX
40%
Loosely correlated
-2.71%
ABCL - PRAX
38%
Loosely correlated
-1.00%
BHVN - PRAX
36%
Loosely correlated
-6.69%
RAPP - PRAX
35%
Loosely correlated
-1.29%
VERU - PRAX
35%
Loosely correlated
+4.20%
More